Compugen discovers drug target for multiple myeloma treatment

Compugen discovers drug target for multiple myeloma treatment
Compugen Ltd announced the discovery and initial experimental validation of CGEN-928 as a drug target for the treatment of multiple myeloma.

Read more on PharmaBiz

More Meth Drug Addiction Info:

• Resveratrol Trial In Multiple Myeloma Suspended Due To Safety …
• An Overview Of Myeloma Treatment Options In Europe – Part 3 …
• Guide To Clinical Trials For Myeloma Patients – Part 3: Myths And …
• Pat's Place: Joining A Support Group Saved My Life — So Why Aren't …
• An Overview Of Myeloma Treatment Options In Europe – Part 1: Drug …
• Multiple myeloma and cytoxan prognosis | Gasterbato.spb.su medical …
• Buckrun Outdoors » Blog Archive » Metabolic vulnerability in …
• From Small Acorns | Myeloma Planet
• Patient Myeloma Blogs in one place | Beth Morgan Multiple Myeloma …
• Researchers Discover Metabolic Vulnerability in TB and Potential …